Mylan has announced its US subsidiary will launch a generic version of its EpiPen after widespread criticism of price rises for the branded product.
The list price will be US$300 for a two pack carton, a discount of more than 50% to the list price.
Mylan said it would also continue to market branded EpiPens.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Sep 16